Quality of Life and Development of Measures in Patients With Cancer of the Oral Cavity
Prospective Evaluation of Quality of Life and Development of Measures in Patients With Cancer of the Oral Cavity
1 other identifier
observational
164
1 country
1
Brief Summary
The purpose of this study is to learn more about the quality of life and emotional changes that patients experience during their treatment for cancer of the mouth. We want to learn more about the emotional and quality of life problems that occur during and after treatment. This will help us better understand these complex issues and improve treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2004
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2004
CompletedFirst Submitted
Initial submission to the registry
December 21, 2007
CompletedFirst Posted
Study publicly available on registry
December 28, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2014
CompletedOctober 16, 2014
October 1, 2014
9.8 years
December 21, 2007
October 15, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
is to assess quality of life and psychosocial adaptation in patients undergoing treatment for cancer of the oral cavity so that we can develop empirically-informed interventions to improve the adaptation of these patients.
conclusion of study
Secondary Outcomes (3)
Validate two new measures of psychosocial adjustment in patients treated for cancer of the oral cavity and upper aerodigestive SCC: The Shame and Stigma in Head and Neck Cancer Scale and the Demoralization Scale
conclusion of study
Assess patterns of tobacco and/or alcohol use in cancer of the oral cavity survivors.
conclusion of the study
Assess the impact of lifestyle and socio-economic issues on post-therapy quality of life.
conclusion of the study
Study Arms (1)
1
Patients who have been diagnosed with Carcinoma of the oral cavity
Interventions
Patient will fill out questionnaires, initial clinic visit, first post-surgery clinic evaluation and 3, 6, 12, 18 and 24 months following completion of all therapy.
Eligibility Criteria
Patients seen on the Head and Neck Surgery Service, Radiation Oncology Service, Medical Oncology Service and Dental Service.
You may qualify if:
- Carcinoma of the oral cavity including one or more of the following anatomic sub-sites: Anterior 2/3rds of the tongue, the floor of the mouth, the upper and lower gums, buccal mucosa, retromolar trigone, hard palate and minor salivary glands.
- Surgically resectable disease in the oral cavity and the neck.
- Patients with prior cancers other than Head and Neck cancers who are currently in remission, have no evidence of disease and are not undergoing any active chemotherapy or radiation therapy.
You may not qualify if:
- Primary tumor of the lips (these are skin cancers).
- Surgical treatment excluding diagnostic biopsy of the primary site or biopsy of neck node/s prior to referral to MSKCC.
- Surgically unresectable disease in the neck; including carotid encasement, massive dermal infiltration, and other clinical and radiographic findings which would preclude surgically resectable nodal disease in the neck, prior to initiation of treatment.
- Evidence of distant metastases by clinical or radiographic examination.
- Patients with more than one simultaneous primary tumor.
- Patient unable to read or comprehend the content of the questionnaires due to language barriers or psychiatric disorders.
- Upper aerodigestive squamous cell carcinoma, including the oropharynx, hypopharynx and larynx - newly diagnosed or recurrent cancers.
- Newly diagnosed and recurrent carcinoma of the oral cavity including one or more of the following anatomic sub-sites: Anterior 2/3rds of the tongue, the floor of the mouth, the upper and lower gums, buccal mucosa, retromolar trigone, hard palate and minor salivary glands.
- Primary tumor of the lips (these are skin cancers).
- Patient unable to read or comprehend the content of the questionnaires due to language barriers or psychiatric disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Memorial Sloan Kettering Cancer Centerlead
- Monash Universitycollaborator
Study Sites (1)
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Snehal Patel, MD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 21, 2007
First Posted
December 28, 2007
Study Start
December 1, 2004
Primary Completion
October 1, 2014
Study Completion
October 1, 2014
Last Updated
October 16, 2014
Record last verified: 2014-10